Skin grafting is a type of medical grafting involving the transplantation of skin. The transplanted tissue is called a skin graft.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that doctors in Taiwan have reported positive results from using ReCell® to treat burn victims of June’s waterpark disaster, with medics saying they have seen superior wound closure and better outcomes.
Here's another discovery to bolster the case for medical marijuana: New research in mice suggests that THC, the active ingredient in marijuana, may delay the rejection of incompatible organs.
Maggot, or larval, therapy has been around since ancient times as a way to heal wounds. Now, the method has gone high-tech--in some ways--and it's being tested in a rigorous clinical trial at the Malcom Randall Veterans Affairs (VA) Medical Center in Gainesville, Fla. Recruitment is now underway.
Avita Medical Ltd., a regenerative medicine company specializing in the treatment of wounds and skin defects, has donated a number of free ReCell devices and sent personnel experienced in burn treatment to provide any support requested by authorities in Taiwan, where hundreds of people have been left seriously burned in a mass casualty event at a waterpark.
A complete skin grafting solution for burns and trauma surgery enabling flexibility of thin and thick skin grafts will be launched by Surtex Instruments at Hospitalar 2015.
A research team bringing together José Cohen and Philippe Grimbert (Inserm Unit 955/Université Paris Est Créteil [UPEC] and the Centre for Clinical Investigation - Biotherapies 504 [CIC-BT 504]), and their collaborators at Institut Curie and AP-HP (George Pompidou European Hospital) has succeeded in finding a combination of drugs that reduces the risk of rejection following a skin graft.
These are exciting times for regenerative medicine. Unlike conventional medicines, the regenerative approach can potentially work to restore the lost functionality of tissues or organs—the major reason for intensive focus on research and development in the field.
A specially-bred strain of miniature swine lacking the molecule responsible for the rapid rejection of pig-to-primate organ transplants may provide a new source of skin grafts to treat seriously burned patients.
Researchers at the University Children's Hospital Zurich and the University of Zurich have engineered skin cells for the very first time containing blood and lymphatic capillaries. They succeeded in isolating all the necessary types of skin cells from human skin tissue and engineering a skin graft that is similar to full-thickness skin.
Untreated, the mortality probably exceeds 70%. Flesh eating is a description of Toxic Inflammatory Cellulitis which usually starts by bacterial subcutaneous infection followed by freezing in phase II healing which is inflammatory.
NJIT Distinguished Professor and electrical engineer Atam Dhawan hits the lecture trail again this summer as a distinguished speaker for an IEEE life sciences lecture series.
Better body armor and rapid aeromedical evacuations enable American service members to survive blasts that would have proved fatal in Vietnam or even the first Gulf War, but they pose new challenges to military medicine - how to deal with the excruciating pain of injuries, especially severe burns from IED blasts that body armor can't protect.
A parasitic worm may hold the answer to keeping skin grafts firmly in place over wounds, according to a new study by researchers at Brigham and Women's Hospital (BWH).
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today summarized new data highlighting the progress of OncoMed's pipeline of anti-cancer biologics presented this week in an oral presentation and five posters at the Annual Meeting of the American Association of Cancer Research in Washington, DC.
Liverpool’s Spire Hospital is using a new technology to heal chronic wounds.
Surgeons have devised a system to help determine the severity of high nipple-areola complex in patients after cosmetic or reconstructive breast surgery.
Arteriocyte, a leading biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts announced today approval from the Food and Drug Administration (FDA) to initiate a Phase I clinical trial using its Magellan System technology in the treatment of thermal burn wounds.
A free partial latissimus dorsi myocutaneous flap can be used for the treatment of severe contracture of the Achilles tendon and posterior ankle in children, and achieves satisfactory form and function, the results of a case series indicate.
Most fingertip injuries can be treated without surgery, research from a large New York City public hospital suggests.
A spray consisting of a mixture of keratinocyte and fibroblast skin cells holds promise for treatment of venous leg ulcers, show results from a phase II randomized controlled trial published in The Lancet.